GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 18,319 shares, a decline of 64.1% from the June 30th total of 50,980 shares. Based on an average daily volume of 59,199 shares, the days-to-cover ratio is presently 0.3 days.
GeneDx Stock Performance
NASDAQ WGSWW opened at $0.00 on Monday. GeneDx has a 52 week low of $0.00 and a 52 week high of $0.13.
About GeneDx
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Further Reading
- Five stocks we like better than GeneDx
- Meta Earnings Put AI Spending and Ad Growth Back in Focus
- These 3 AI Winners Don’t Sell the Tech—They Use It
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
